| ¿µ¹® | parenteral administration of drugs | ÇÑ±Û | ºñ°æ±¸Àû ¾àǰÅõ¿© |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù. 1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇÏ´Â °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù. 2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁÖ·Î ¾Ë·¯Áö ȯÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, ȤÀº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁÖ·Î ÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª ȤÀº õõÈ÷ ÀÛ¿ëÇÏ´Â ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù. 4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» ÁÖ´Â ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù. 5) ¼ö¸·°³»ÁÖ»ç: intrathecal injection-µÎ°³³ª ô¼ö°³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù. 6)°³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | rectal administration of drugs | ÇÑ±Û | ¾à¹°ÀÇ °ðâÀÚÁ¾à½Ä Åõ¿© |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ÅëÇØ ¸ÔÀº ¾à¹°Àº Èí¼öµÈ ÈÄ °£À» °ÅÃÄ º´º¯ºÎÀ§·Î ¿î¹ÝµÈ´Ù. µû¶ó¼ °£¿¡¼ ´ë»ç°¡ µÇ¾î ¾à¹°·Î¼ÀÇ È¿°ú°¡ ¾ø¾îÁú °¡´É¼ºÀÌ ÀÖÀ» »Ó ¾Æ´Ï¶ó °£¿¡ µ¶¼ºÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ÀÌ·¯ÇÑ ´ÜÁ¡À» º¸¿ÏÇϱâÀ§ÇØ °£À» ÅëÇÏÁö ¾Ê°í À绡¸® Èí¼öµÇ¾î º´º¯À¸·Î °¥ ¼ö ÀÖ´Â ¹æÆíÀ¸·Î Á÷ÀåÁ¾àÀ» »ç¿ëÇÑ´Ù. Á÷ÀåÀÇ Á¤¸ÆÈ帧Àº °£À» °ÅÄ¡Áö ¾Ê°í Á÷Á¢ ÇÏ´ëÁ¤¸ÆÀ» ÅëÇØ ¿ì½É¹æÀ¸·Î Èê·¯µé±â ¶§¹®ÀÌ´Ù. |
||
| ¿µ¹® | side effects of drugs | ÇÑ±Û | ¾à¹°ÀÇ ºÎÀÛ¿ë |
|---|---|---|---|
| ¼³¸í | ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇÏ´Â È¿°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇÏ´Â ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó. |
||
| CSC | blow on blow (administration of small amounts of drugs at short intervals) [Fr. coup sur coup]; coll... |
|---|---|
| BCDSP | Boston Collaborative Drug Surveillance Program |
| CDSC | Communicable Diseases Surveillance Centre [London] |
| COMPASS | Computerized Online Medicaid Pharmaceutical Analysis and Surveillance System |
| CSS | Cancer Surveillance System; carotid sinus stimulation; carotid sinus syndrome; cavernous sinus syndr... |
| ATD | Antithyroid drugs |
|---|---|
| DMARD | Disease Modifying Antirheumatic Drugs |
| NSAID | Non Steroid Anti-Inflammatory Drugs |
| SAARD | Slow Acting Anti-Rheumatic Drugs |
| COC | Combined oral contraceptive |
| cancer, colon: screening and surveillance | Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer. (12 Dec 1998) |
|---|---|
| population surveillance | <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. (12 Dec 1998) |
| post-marketing surveillance | Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc. (05 Mar 2000) |
| product surveillance, postmarketing | Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale. (12 Dec 1998) |
| sentinel surveillance | Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. To estimate trends in larger population. (12 Dec 1998) |
| surveillance | Oversight; watch; inspection; supervision. "That sort of surveillance of which . . . The young have accused the old." (Sir W. Scott) Origin: F, fr. Surveiller to watch over; sur over + veiller to watch, L. Vigilare. See Sur-, and Vigil. Source: Websters Dictionary (01 Mar 1998) |
| immune surveillance | <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells. (18 Nov 1997) |
| immunological surveillance | <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells. (18 Nov 1997) |
| immunologic surveillance | The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells. (12 Dec 1998) |
| veterinary drugs | Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products. (12 Dec 1998) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| psychotropic drugs | A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents). (12 Dec 1998) |
| neuroleptic drugs | Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine. Origin: Gr. Lepsis = a taking hold (18 Nov 1997) |
| street drugs | Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity. (12 Dec 1998) |
| designer drugs | Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|